Jane Street’s SpringWorks Therapeutics SWTX Stock Holding History

Jane Street’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-26,300	Closed	-$1.24M	–	11742
2025 Q2	$1.24M	Sell	26,300 -70,700	-73%	-$3.15M	﹤0.01%	5222
2025 Q1	$4.28M	Sell	97,000 -50,400	-34%	-$2.32M	﹤0.01%	3164
2024 Q4	$5.33M	Buy	147,400 +33,200	+29%	+$1.16M	﹤0.01%	2576
2024 Q3	$3.66M	Sell	114,200 -24,600	-18%	-$919K	﹤0.01%	3381
2024 Q2	$5.23M	Buy	+138,800	New	+$5.84M	﹤0.01%	2912
2024 Q1	–	Sell	-13,600	Closed	-$496K	–	10055
2023 Q4	$496K	Buy	+13,600	New	+$355K	﹤0.01%	6764
2022 Q4	–	Sell	-17,900	Closed	-$511K	–	10124
2022 Q3	$511K	Buy	17,900 +9,200	+106%	+$264K	﹤0.01%	6655
2022 Q2	$214K	Buy	+8,700	New	+$318K	﹤0.01%	8102

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Jane Street's SWTX Position: Q3 2025 in Review

Jane Street sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 70,814 shares — an estimated $3.33M sold.

Jane Street first reported a position in SWTX in Q3 2019 and held it in 17 quarters. The position peaked at $28.6M in Q1 2024. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Jane Street reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Jane Street sold 70,814 SpringWorks Therapeutics shares in Q3 2025, an estimated $3.33M.
Jane Street first reported a position in SpringWorks Therapeutics in Q3 2019 and held it in 17 quarters.
Jane Street's SpringWorks Therapeutics position peaked at $28.6M in Q1 2024.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Jane Street's 13F filing for Q3 2025, filed 14 Nov 2025.